tast
good
sweeten
cherryflavour
formul
antimalari
effect
convent
bitter
pill
rais
hope
children
like
finish
cours
antimalari
salim
abdulla
ifakara
health
institut
tanzania
compar
effici
sweet
antimalari
pill
contain
artemetherlumefantrin
design
dispers
water
convent
pill
bitter
dissolv
water
children
age
year
younger
benin
kenya
mali
mozambiqu
tanzania
sweet
pill
cure
rate
convent
pill
cure
rate
children
prefer
cherryflavour
medic
improv
effect
treatment
malaria
say
abdullah
flavour
pill
receiv
regulatori
approv
distribut
children
countri
malaria
endem
flavour
pill
expect
cost
convent
bitter
pill
lancetscidevnet
trace
tb
origin
skeleton
woman
infant
provid
earliest
verifi
evid
human
tuberculosi
tb
israel
hershkovitz
tel
aviv
univers
israel
colleagu
excav
bone
alityam
neolith
villag
israel
date
year
ago
bone
characterist
legion
tb
pcr
use
identifi
five
mycobacterium
tuberculosi
genet
loci
bone
sampl
find
show
human
tb
year
older
previous
thought
also
shed
new
light
origin
tb
infect
organ
definit
human
strain
tb
contrast
origin
theori
human
tb
evolv
bovin
tb
anim
domest
say
studi
colead
helen
donoghu
univers
colleg
london
centr
infecti
diseas
intern
health
unit
kingdom
author
argu
wherea
domest
anim
sourc
tb
may
support
denser
human
popul
therebi
facilit
transmiss
tb
plo
onehealthday
polio
vaccin
success
nigeria
monoval
oral
polio
vaccin
introduc
make
inroad
erad
polio
nigeria
helen
jenkin
imperi
colleg
london
unit
kingdom
colleagu
found
new
monoval
oral
vaccin
type
polio
common
form
polio
nigeria
provid
coverag
singl
dose
time
effect
previous
use
trival
oral
vaccin
provid
coverag
serotyp
polio
singl
dose
furthermor
vaccineinduc
immun
level
children
age
doubl
despit
optim
effect
monoval
vaccin
increas
uptak
level
increas
coverag
nigerian
state
still
requir
author
write
n
engl
j
medbbc
sti
electron
age
email
internet
revolution
way
commun
one
anoth
even
use
inform
peopl
might
sexual
transmit
infect
sti
inspot
internet
servic
allow
peopl
inform
sexual
partner
may
risk
sti
use
peopl
send
ecard
sinc
site
launch
sender
remain
anonym
choos
receiv
provid
link
testsit
sti
inform
deb
levin
execut
director
internet
sexual
inform
servic
colleagu
report
plo
medicin
inspot
potenti
nation
intern
resourc
mobil
phone
also
increasingli
use
public
health
messag
start
decemb
project
masilulek
send
one
million
free
text
messag
day
south
africa
encourag
peopl
get
test
treat
hiv
aid
india
capella
rington
repeat
word
condom
time
alreadi
download
time
sinc
launch
august
plo
medlo
angel
timesbbcnatur
med
defeat
diarrhoea
oral
vaccin
rotaviru
reduc
incid
infect
unit
state
dramat
year
rotaviru
caus
vomit
diarrhoea
respons
thousand
hospit
unit
state
kill
half
million
children
global
jay
lieberman
focu
diagnost
california
colleagu
assess
rotaviru
test
result
past
year
found
rate
infect
fallen
sinc
vaccin
introduc
merckmanufactur
rotateq
vaccin
administ
dose
month
notabl
rotaviru
infect
rate
even
fell
nonimmun
older
children
old
vaccin
less
like
infect
older
brother
sister
children
daycar
nt
vaccin
say
lieberman
accord
cdc
data
onethird
month
old
receiv
dose
vaccin
effort
underway
make
rotateq
rotarix
similar
vaccin
manufactur
glaxosmithklin
approv
food
drug
administr
fda
april
avail
develop
countri
icaacidsabloombergreut
hiv
rebound
although
combin
antiretrovir
therapi
cart
use
suppress
hiv
level
hiv
quickli
becom
resurg
unknown
mechan
cart
interrupt
perform
longitudin
clonal
evolutionari
studi
patient
chronic
infect
undergon
structur
treatment
interrupt
beda
joo
univers
hospit
zurich
switzerland
colleagu
show
rebound
viru
homogen
suggest
viru
monoclon
oligoclon
origin
reactiv
find
indic
contrari
expect
hiv
rebound
latent
infect
cell
rather
continu
low
level
replic
viru
jeffrey
laurenc
director
laboratori
aid
viru
research
weill
medic
colleg
cornel
univers
new
york
say
studi
impli
current
antihiv
drug
regimen
potent
complet
block
viral
replic
celltocel
transmiss
viru
proc
natl
acad
sci
usahealthday
one
one
combin
three
drug
highli
effect
prevent
replic
influenza
viru
potenti
provid
new
strategi
control
outbreak
avian
flu
report
annual
meet
jack
nguyen
adama
pharmaceut
california
colleagu
test
combin
therapi
call
tripl
combin
antivir
drug
tcad
cell
cultur
mous
model
influenza
owe
surpris
unanticip
synergist
interact
three
drug
tcad
block
replic
sever
influenza
subtyp
includ
accord
author
wherea
threedrug
combin
proven
effect
control
infect
hiv
import
yet
realiz
influenza
viru
author
add
tcad
repres
viabl
solut
meet
treatment
challeng
yearli
influenza
epidem
potenti
pandem
includ
deadli
strain
icaacidsa
bad
blood
patient
receiv
blood
store
day
longer
much
higher
risk
contract
hospitalacquir
diseas
patient
receiv
blood
store
day
current
fda
regul
stipul
blood
must
discard
day
storag
howev
david
gerber
cooper
univers
hospit
camden
new
jersey
colleagu
report
patient
receiv
blood
day
older
twice
like
succumb
infect
includ
pneumonia
urinarytract
infect
sepsi
result
announc
meet
american
colleg
chest
physician
base
observ
patient
receiv
blood
transfus
juli
septemb
despit
observ
gerber
endors
chang
fda
regul
would
reduc
avail
blood
suppli
reuter
power
media
diseas
think
sever
anthrax
tularaemia
accord
recent
find
meredith
young
colleagu
mcmaster
univers
canada
percept
diseas
sever
depend
much
coverag
differ
diseas
receiv
media
research
ask
psycholog
medic
student
consid
ten
diseas
either
high
anthrax
west
nile
viru
avian
flu
sever
acut
respiratori
syndrom
sar
lyme
diseas
low
tularaemia
yellow
fever
hantaviru
lassa
fever
human
babesiosi
media
coverag
rate
diseas
sever
diseaselik
statu
preval
particip
consid
diseas
occur
frequent
media
seriou
infrequ
occur
media
even
low
media
frequenc
condit
consid
object
wors
separ
group
student
author
report
moreov
found
estim
sever
also
posit
correl
popular
print
media
frequenc
thank
student
also
abl
make
nonmediadepend
decis
sever
differ
diseas
given
object
inform
diseas
plo
onehealthday
cure
crohn
crohn
diseas
could
caus
lack
faecalibacterium
prausnitzii
report
harri
sokol
institut
nation
de
la
recherch
agronomiqu
franc
colleagu
previou
find
show
decreas
abund
biodivers
firmicut
intestin
patient
crohn
diseas
build
find
sokol
colleagu
use
fluoresc
situ
hybrid
analys
mucosaassoci
microbiota
patient
crohn
diseas
time
surgic
resect
treatment
method
crohn
diseas
month
later
found
reduct
f
prausnitzii
associ
higher
risk
recurr
moreov
oral
administr
either
f
prausnitzii
supernat
reduc
sever
mous
model
coliti
author
propos
f
prausnitzii
exhibit
antiinflammatori
effect
cellular
mous
model
coliti
part
secret
metabolit
block
nuclear
activ
product
result
suggest
use
f
prausnitzii
probiot
promis
strategi
crohn
diseas
treatment
author
conclud
proc
natl
acad
sci
usabbc
outbreak
news
arenaviru
infect
mysteri
diseas
kill
three
peopl
zambia
south
africa
identifi
viru
arenavirida
famili
septemb
tour
guid
lusaka
zambia
evacu
johannesburg
south
africa
show
symptom
fever
mylagia
vomit
diarrhoea
rash
liver
dysfunct
convuls
die
paramed
intensivecareunit
nurs
care
patient
later
develop
similar
symptom
also
die
total
seven
case
infect
report
arenavirus
frequent
carri
rodent
first
identif
arenaviru
caus
human
diseas
southern
african
countri
whoeurosurveil
news
compil
assist
david
ojciu
univers
california
merc
usa
david
link
infecti
diseas
news
stori
access
connotea
http
wwwconnoteaorg
usernam
naturerevmicrobiol
